Uses Of Neuregulin In Preventing, Treating Or Delaying Ventricular Arrhythmia, And Composition Thereof

Patent No. EP3199174 (titled "Uses Of Neuregulin In Preventing, Treating Or Delaying Ventricular Arrhythmia, And Composition Thereof") was filed by Zensun Shanghai Science And Technology on Sep 6, 2015. The application was issued on Apr 13, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANJan 13, 2023CMS CAMERON MCKENNA NABARRO OLSWANG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3199174

ZENSUN SHANGHAI SCIENCE AND TECHNOLOGY
Application Number
EP15845381A
Filing Date
Sep 6, 2015
Status
Revoked
Jan 10, 2025
Publication Date
Apr 13, 2022